We Are Proud that Our Readership Overwhelmingly Tells Us that “Everyone in the Device Industry Should be Reading The MedTech Strategist.”
ONCE-A-YEAR $1495 SUMMER SPECIAL ENDS SOON – Subscribe Today!
The MedTech Strategist, a key information and investment conferences provider serving the global medical technology industry, is led by our co-editors-in-chief David Cassak and Stephen Levin and a seasoned editorial team and staff. We launched The MedTech Strategist, a publication broadly covering the most important topics and trends in medical devices today, in September 2014. Featuring a wide range of editorial offerings — from interviews with industry leaders to stories on leading companies, profiles of ground-breaking start-ups and analyses of dynamic clinical markets and technology trends — The MedTech Strategist, in essence, explores how innovation plays out in all of its various forms — clinical, technological, business model, marketplace, and financing — in the global medical device arena.
The MedTech Strategist has been busy setting a different standard in device industry publications. Our seasoned editorial team provides not only insight on trends that we foresee in the global device space, in most cases months before it is announced in the general press, but also puts this in context for you as you assess your current portfolio and business challenges. We provide you and your team with essential global industry perspective, including insight and analysis that is currently sorely missing in the medtech industry. See our recent coverage here.
The MedTech Strategist Offers:
- Smart, informed analysis of global device market dynamics and trends, including coverage 38 key topic areas/markets
- Editorial content backed by unparalleled device industry experience and knowledge: Editors-in-Chief David Cassak and Stephen Levin, and our seasoned editorial team
- Our writing team is an integral part of the global medical device ecosystem; read testimonials here
Who Reads Us?
- Our extensive readership primarily includes presidents, VPs, directors, business development, marketing, innovation groups, etc., within the device industry to include start-up medical device companies, venture capital firms, investment banks, service providers, and large corporate companies and others that have global licenses to our publication, including: Medtronic, Covidien, Johnson & Johnson, Johnson & Johnson Development Corp., Edwards Lifesciences, Maquet Cardiovascular, SV Life Sciences Advisers, Fjord Ventures, WSGR, Bain & Company, Leerink, WL Gore, Hologic, Cardinal Health, Integra LifeSciences, B.Braun/Aesculap, Arboretum Ventures, Endeavour Vision, LivaNova, NEA, Fountain Healthcare Partners, Cleveland Clinic, BioInnovate Ireland, Peppermint Venture Partners, Terumo, The Foundry, and Roche, just to name a few.